Education
About Us
Working with TipRanks
Follow Us
Alzinova AB (SE:ALZ)
:ALZ
ALZ Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr1.10 - kr4.40
Previous CloseN/A
Volume98.89K
Average Volume (3M)801.92K
Market Cap
€119.97M
Enterprise Valuekr137.63M
Total Cash (Recent Filing)€11.51M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.03
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding104,323,586
10 Day Avg. Volume706,860
30 Day Avg. Volume801,916
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.55Price Target Upside34.59% Upside
Rating ConsensusHold
Number of Analyst Covering0
ALZ FAQ
What was Alzinova AB’s price range in the past 12 months?
Alzinova AB lowest stock price was kr1.10 and its highest was kr4.40 in the past 12 months.
What is Alzinova AB’s market cap?
Alzinova AB’s market cap is €119.97M.
When is Alzinova AB’s upcoming earnings report date?
Alzinova AB’s upcoming earnings report date is Nov 13, 2025 which is in 55 days.
How were Alzinova AB’s earnings last quarter?
Alzinova AB released its earnings results on Aug 21, 2025. The company reported -kr0.083 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.083.
Is Alzinova AB overvalued?
According to Wall Street analysts Alzinova AB’s price is currently Undervalued.
Does Alzinova AB pay dividends?
Alzinova AB does not currently pay dividends.
What is Alzinova AB’s EPS estimate?
Alzinova AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alzinova AB have?
Alzinova AB has 104,323,586 shares outstanding.
What happened to Alzinova AB’s price movement after its last earnings report?
Alzinova AB reported an EPS of -kr0.083 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.947%.
Which hedge fund is a major shareholder of Alzinova AB?
Currently, no hedge funds are holding shares in SE:ALZ
Company Description
Alzinova AB
Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden. Its lead candidate is ALZ-101, an oligomer-specific vaccine for the treatment of Alzheimer's disease; and ALZ-201, a monoclonal antibody that is used for the treatment of toxic Aß oligomers. The company was founded in 2011 and is based in Mölndal, Sweden.
Technical Analysis
Biosergen AB
―
Nanologica AB
―
Biovica International AB Class B
―
Modus Therapeutics Holding AB
―
NextCell Pharma AB
―